Project ID: D2016-49 IP Status: PCT patent application filed Invention Description and Novelty: GRβ has been shown to increase growth and migration of cancer cells. Newly designed molecule suppresses GRβ to inhibit expression and migration of the cancer. Sweet-P is the only compound that has b.....
[更多]
Our scientists have identified a previously unrecognized molecular pathway involving a series of protein‐protein interactions that underlies glutamate (GluR2) containing - α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) receptor mediated excitotoxicity as a novel target for treatment of .....
[更多]
CAMH scientists have identified an interaction between dopamine transporter DAT and the presynaptic dopamine type 2 receptor (D2) which is thought to be an underlying cause for Attention Deficit Hyperactivity Disorder (ADHD). By characterizing this interaction, our scientists have developed a peptid.....
[更多]
Synthetic vaccine and Immunogenic Fusion Proteins for pneumococcal infections (SJ-05-0036, SJ-10-0028, SJ-13-0032).A vaccine comprising synthetically linked domains of choline binding protein A (C
[更多]
| |< <- | [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] | -> >| |
